Analyst consensus rating
Acumen Pharmaceuticals Analyst Rating: Hold
Direct answer
Acumen Pharmaceuticals's consensus rating is Hold.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $1.00.
Forecast evidence checked November 4, 2026.
Get free Acumen Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.23
- Average price target
- $1.00
- High price target
- $1.00
- Low price target
- $1.00
- Low target gap
- +326.6%
- Target upside
- +326.6%
- High target gap
- +326.6%
- Target range width
- 0%
- Consensus rating
- Hold
- Analysts
- 5
- Evidence date
- November 4, 2026
- Valid through
- November 11, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Acumen Pharmaceuticals?
Acumen Pharmaceuticals has a verified Hold consensus. The same dataset has an average price target of $1.00.
How far are Acumen Pharmaceuticals's low and high targets from the recorded price?
The low target implies +326.6%, while the high target implies +326.6%.
How many analysts are included in Acumen Pharmaceuticals's consensus?
The verified consensus includes 5 analysts.
How is Acumen Pharmaceuticals's target upside or downside calculated?
The average target of $1.00 is divided by the recorded price of $0.23, then one is subtracted to produce +326.6%. This does not guarantee a future return.
When was Acumen Pharmaceuticals's analyst forecast verified?
The data was verified on 2026-11-04. The dataset is valid through 2026-11-11.